What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains

Recent financial reports highlight significant insider trading activities within Kestra and TransMedics. A Kestra insider executed a sale totaling $312,000 following a 25% increase in stock value. Conversely, a TransMedics insider sold shares worth $722,000 after the company experienced a 45% drop in stock price. These transactions reflect contrasting market movements for the two entities, as one insider capitalized on gains while the other sold during a period of substantial decline.